Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page

Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 22, which means every article in Journal of Vaccines & Vaccination has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.

  2022 2021 2020 2019 2018

Year wise published articles

59 65 71 11 19

Year wise citations received

174 249 218 197 194
Journal total citations count 2051
Journal Impact Factor 2.87
Journal 5 years Impact Factor 3.73
Journal CiteScore 4.69
Journal h-index 22
Important citations

Ingwe R (2014) Why Access to Electricity is a Big Deal for Nigeria's Development and its Linkages to Poverty, Security and Disease. Valahian Journal of Economic Studies 5: 45.

Sini TI, Nden ZP, Livinus JC, Rinle KP, Ademola OP, et al. (2015) Human Exposure to Dog Rabies in Rural Africa. Journal of Medical Microbiology & Diagnosis 4: 1.

Ishaya TS, Ibironke OC, Stella IE, Olatunde AB, Gyang MD, et al. (2016) Dog Bites and Rabies: A Decade Perspective in Nigeria (2005-2014). World 6: 19-24.

Earla P (2014) Ancient Diseases-Microbial Impact. Journal of Ancient Diseases & Preventive Remedies.

Kiseleva I, Dubrovina I, Fedorova E, Larionova N, Isakova–Sivak I, et al. (2015) Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. Vaccine 33: 7008-7014.

Rekstin A, Isakova-Sivak I, Petukhova G, Korenkov D, Losev I, et al. (2017) Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein. BioMed Research International.

Fisher BL (2014) The Emerging Risks of Live Virus & Virus Vectored Vaccines. National Vaccination Information Center.

Kiseleva I, Larionova N, Fedorova E, Isakova-Sivak I, Rudenko L (2015) New methodological approaches in the development of russian live attenuated vaccine for pandemic influenza. Translational Biomedicine.

Rudenko L, Yeolekar L, Kiseleva I, Isakova-Sivak I (2016) Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: process challenges and success stories. Vaccine 34: 5436-5441.

Rudenko L, Isakova-Sivak I (2015) Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. Expert review of vaccines 14: 395-412.

Rudenko L, Kiseleva I, Stukova M, Erofeeva M, Naykhin A, et al. (2015) Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: Results from a placebo-controlled, randomized double-blind phase I study. Vaccine 33: 5110-5117.

Balenović M, Zelenika TA, Janječić Z, Carović-Stanko K, Popović M, et al. (2015) Effect of sweet basil (Ocimum basilicum cv.'Genovese') in laying hen feed on humoral and cellular immunity. InXI. simpozij Peradarski dani s međunarodnim sudjelovanjem.

Morales-Cartagena A, Lalueza A, López-Medrano F, Juan RS, Aguado JM, et al. (2015) WJCID. World 5: 14-50.

Wernik R, Priore JL, Goldman WF, Borkow G, del Carmen Elias A. Name of journal: World Journal of Clinical Infectious Diseases ESPS Manuscript NO: 14079 Columns: ORIGINAL ARTICLE Observational Study Improvement in human immunodeficiency virus-1/acquired immune deficiency syndrome patients’ well-being following administration of “Phyto V7”.

Wernik R, Priore JL, Goldman WF, Elias AC, Borkow G (2015) Improvement in human immunodeficiency virus-1/acquired immune deficiency syndrome patients’ well-being following administration of “Phyto V7”. World J Clin Infect Dis 5: 44-50.

Wernik R, Priore JL, Goldman WF, del Carmen Elias A, Borkow G (2015) WJCID. World 5: 44-50.

Sanei F, Wilkinson T (2016) Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness. Therapeutic advances in respiratory disease 10: 349-367.

Chen-Yu Hsu A, Starkey MR, Hanish I, Parsons K, Haw TJ, et al. (2015) Targeting PI3K-p110α suppresses influenza virus infection in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 191: 1012-1023.

Brown B, Davtyan M, Fisher CB (2015) Peruvian female sex workers’ ethical perspectives on their participation in an HPV vaccine clinical trial. Ethics & behavior 25: 115-128.

Mohn KG, Cox RJ, Tunheim G, Berdal JE, Hauge AG, et al. (2015) Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway. PloS one 10: e0143281.